Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Rentokil
RTO
|
+$510M |
| 2 |
Apellis Pharmaceuticals
APLS
|
+$205M |
| 3 |
TFI International
TFII
|
+$146M |
| 4 |
Ambev
ABEV
|
+$133M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$132M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.18B |
| 3 |
Mastercard
MA
|
+$3.67B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.38B |
| 5 |
Amazon
AMZN
|
+$3.16B |
Sector Composition
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.68% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CRISPR Therapeutics
CRSP
$5.08B
| $539K | ﹤0.01% |
13,262
-13,262
| -50% | -$539K |
|
1677
Park Hotels & Resorts
PK
$2.4B
| $538K | ﹤0.01% |
45,675
-45,681
| -50% | -$538K |
|
1678
M/I Homes
MHO
$4.14B
| $536K | ﹤0.01% |
11,618
-12,158
| -51% | -$561K |
|
|
PDCO
1679
DELISTED
Patterson Companies, Inc.
PDCO
| $536K | ﹤0.01% |
19,141
-6,943
| -27% | -$195K |
|
1680
Coty
COTY
$3.6B
| $536K | ﹤0.01% |
62,643
-62,653
| -50% | -$536K |
|
|
IBER
1681
DELISTED
Ibere Pharmaceuticals
IBER
| $534K | ﹤0.01% |
52,917
-52,917
| -50% | -$534K |
|
1682
Arrow Electronics
ARW
$6.66B
| $532K | ﹤0.01% |
5,088
+1,603
| +46% | +$168K |
|
|
AXNX
1683
DELISTED
Axonics, Inc. Common Stock
AXNX
| $532K | ﹤0.01% |
8,508
+2,000
| +31% | +$125K |
|
1684
Arcosa
ACA
$4.81B
| $531K | ﹤0.01% |
9,784
| – | – |
|
1685
Beam Therapeutics
BEAM
$2.18B
| $531K | ﹤0.01% |
13,579
-6,961
| -34% | -$272K |
|
1686
EPR Properties
EPR
$4.31B
| $531K | ﹤0.01% |
14,083
-14,083
| -50% | -$531K |
|
1687
Bankunited
BKU
$2.96B
| $531K | ﹤0.01% |
15,627
-10,227
| -40% | -$347K |
|
|
ATSG
1688
DELISTED
Air Transport Services Group, Inc.
ATSG
| $531K | ﹤0.01% |
+20,429
| New | +$531K |
|
1689
Guardant Health
GH
$7.08B
| $530K | ﹤0.01% |
19,517
-15,319
| -44% | -$416K |
|
|
NAAC
1690
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $529K | ﹤0.01% |
52,305
-52,303
| -50% | -$529K |
|
1691
Kulicke & Soffa
KLIC
$2.03B
| $529K | ﹤0.01% |
11,946
-11,946
| -50% | -$529K |
|
|
NHIC
1692
DELISTED
NewHold Investment Corp. II Class A Common Stock
NHIC
| $528K | ﹤0.01% |
52,725
-52,725
| -50% | -$528K |
|
1693
Federated Hermes
FHI
$4.2B
| $528K | ﹤0.01% |
14,548
-15,912
| -52% | -$578K |
|
|
PNTM
1694
DELISTED
Pontem Corporation
PNTM
| $527K | ﹤0.01% |
+52,133
| New | +$527K |
|
1695
Tri Pointe Homes
TPH
$3.18B
| $527K | ﹤0.01% |
28,328
-29,884
| -51% | -$555K |
|
1696
Otter Tail
OTTR
$3.52B
| $526K | ﹤0.01% |
8,968
+393
| +5% | +$23.1K |
|
1697
CNO Financial Group
CNO
$3.83B
| $525K | ﹤0.01% |
23,002
-23,004
| -50% | -$526K |
|
1698
Papa John's
PZZA
$1.64B
| $524K | ﹤0.01% |
6,363
| – | – |
|
|
KRNL
1699
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $523K | ﹤0.01% |
51,790
-51,790
| -50% | -$523K |
|
1700
CONMED
CNMD
$1.67B
| $521K | ﹤0.01% |
5,882
| – | – |
|